Order Article Reprints

Salvador-Martín S, Kaczmarczyk B, Álvarez R, Navas-López VM, Gallego-Fernández C, Moreno-Álvarez A, Solar-Boga A, Sánchez C, Tolin M, Velasco M, et al. Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics. 2021; 13(1):77. https://doi.org/10.3390/pharmaceutics13010077

Salvador-Martín, Sara, Bartosz Kaczmarczyk, Rebeca Álvarez, Víctor Manuel Navas-López, Carmen Gallego-Fernández, Ana Moreno-Álvarez, Alfonso Solar-Boga, Cesar Sánchez, Mar Tolin, Marta Velasco, and et al. 2021. "Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease" Pharmaceutics 13, no. 1: 77. https://doi.org/10.3390/pharmaceutics13010077

Salvador-Martín, S., Kaczmarczyk, B., Álvarez, R., Navas-López, V. M., Gallego-Fernández, C., Moreno-Álvarez, A., Solar-Boga, A., Sánchez, C., Tolin, M., Velasco, M., Muñoz-Codoceo, R., Rodriguez-Martinez, A., Vayo, C. A., Bossacoma, F., Pujol-Muncunill, G., Fobelo, M. J., Millán-Jiménez, A., Magallares, L., Martínez-Ojinaga, E., ... López-Fernández, L. A. (2021). Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics, 13(1), 77. https://doi.org/10.3390/pharmaceutics13010077